MyFinsight
Home
Blog
About
Cash and cash
equivalents
$11,337K
(-6.46%↓ Y/Y)
Tax credit
receivable
$1,681K
(-2.38%↓ Y/Y)
Prepaid expenses and
other current assets
$653K
(-27.52%↓ Y/Y)
In-process research and
development
$19,064K
(-2.85%↓ Y/Y)
Total current assets
$13,671K
(-7.27%↓ Y/Y)
Right of use asset
$1,825K
(69.45%↑ Y/Y)
Property and equipment,
net
$173K
(-32.95%↓ Y/Y)
Deposits and other assets
$80K
(-2.44%↓ Y/Y)
Restricted cash
$44K
(-4.35%↓ Y/Y)
Total assets
$34,857K
(-2.72%↓ Y/Y)
Total liabilities and
stockholders' equity
$34,857K
(-2.72%↓ Y/Y)
Total liabilities
$22,670K
(-10.06%↓ Y/Y)
Total stockholders'
equity
$12,187K
(14.72%↑ Y/Y)
Accumulated deficit
-$363,971K
(-3.30%↓ Y/Y)
Treasury stock at cost,
28,810 shares at june...
$288K
(0.00%↑ Y/Y)
Total current
liabilities
$12,111K
(-2.28%↓ Y/Y)
Non-current contingent
consideration
$7,169K
(-29.44%↓ Y/Y)
Loan payable -
non-current
$1,620K
(-1.16%↓ Y/Y)
Non-current operating lease
liability
$1,374K
(135.27%↑ Y/Y)
Non-current deferred
research and development...
$396K
(-7.91%↓ Y/Y)
Additional paid-in capital
$376,154K
(3.78%↑ Y/Y)
Accumulated other
comprehensive loss
$247K
(-68.85%↓ Y/Y)
Common stock, 0.001 par
value 350,000,000...
$45K
(462.50%↑ Y/Y)
Accrued expenses
$6,418K
(-28.82%↓ Y/Y)
Contingent consideration,
current portion
$2,650K
Deferred research and
development tax...
$1,210K
(-9.90%↓ Y/Y)
Accounts payable
$984K
(62.11%↑ Y/Y)
Operating lease
liability-current portion
$525K
(185.78%↑ Y/Y)
Accrued employee
benefits
$290K
(-61.79%↓ Y/Y)
Loans
payable-current
$34K
(-39.29%↓ Y/Y)
Back
Back
Balance Sheet
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)
source: myfinsight.com